ArticleBlood advances2017

T-cell prolymphocytic leukemia in an adolescent with ataxia-telangiectasia: novel approach with a JAK3 inhibitor (tofacitinib).

Geling Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.